These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37116497)

  • 1. Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling.
    Longarini EJ; Dauben H; Locatelli C; Wondisford AR; Smith R; Muench C; Kolvenbach A; Lynskey ML; Pope A; Bonfiglio JJ; Jurado EP; Fajka-Boja R; Colby T; Schuller M; Ahel I; Timinszky G; O'Sullivan RJ; Huet S; Matic I
    Mol Cell; 2023 May; 83(10):1743-1760.e11. PubMed ID: 37116497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
    Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
    Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dispensability of HPF1 for cellular removal of DNA single-strand breaks.
    Hrychova K; Burdova K; Polackova Z; Giamaki D; Valtorta B; Brazina J; Krejcikova K; Kuttichova B; Caldecott KW; Hanzlikova H
    Nucleic Acids Res; 2024 Oct; 52(18):10986-10998. PubMed ID: 39162207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
    Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
    Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.
    Sun FH; Zhao P; Zhang N; Kong LL; Wong CCL; Yun CH
    Nat Commun; 2021 Feb; 12(1):1028. PubMed ID: 33589610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions.
    Zentout S; Imburchia V; Chapuis C; Duma L; Schützenhofer K; Prokhorova E; Ahel I; Smith R; Huet S
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2322689121. PubMed ID: 38865276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
    Kurgina TA; Lavrik OI
    Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
    Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
    Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation.
    Bonfiglio JJ; Leidecker O; Dauben H; Longarini EJ; Colby T; San Segundo-Acosta P; Perez KA; Matic I
    Cell; 2020 Nov; 183(4):1086-1102.e23. PubMed ID: 33186521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserving ester-linked modifications reveals glutamate and aspartate mono-ADP-ribosylation by PARP1 and its reversal by PARG.
    Longarini EJ; Matić I
    Nat Commun; 2024 May; 15(1):4239. PubMed ID: 38762517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.
    Kurgina TA; Moor NA; Kutuzov MM; Naumenko KN; Ukraintsev AA; Lavrik OI
    Commun Biol; 2021 Nov; 4(1):1259. PubMed ID: 34732825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome.
    Hendriks IA; Buch-Larsen SC; Prokhorova E; Elsborg JD; Rebak AKLFS; Zhu K; Ahel D; Lukas C; Ahel I; Nielsen ML
    Nat Commun; 2021 Oct; 12(1):5893. PubMed ID: 34625544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
    Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I
    Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine ADP-ribosylation reversal by the hydrolase ARH3.
    Fontana P; Bonfiglio JJ; Palazzo L; Bartlett E; Matic I; Ahel I
    Elife; 2017 Jun; 6():. PubMed ID: 28650317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fast-growing business of Serine ADP-ribosylation.
    Longarini EJ; Matic I
    DNA Repair (Amst); 2022 Oct; 118():103382. PubMed ID: 35963141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine is the major residue for ADP-ribosylation upon DNA damage.
    Palazzo L; Leidecker O; Prokhorova E; Dauben H; Matic I; Ahel I
    Elife; 2018 Feb; 7():. PubMed ID: 29480802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair.
    Dhakar SS; Galera-Prat A; Lehtiö L
    Sci Rep; 2024 Feb; 14(1):3875. PubMed ID: 38365924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP1/2 and Accessory Factor HPF1 Interlock to Form a Joint Active Site.
    Cancer Discov; 2020 Apr; 10(4):486. PubMed ID: 32060056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP1 is activated by membrane damage and is involved in membrane repair through poly(ADP-ribosyl)ation.
    Mashimo M; Kita M; Nobeyama A; Nomura A; Fujii T
    Genes Cells; 2022 Apr; 27(4):305-312. PubMed ID: 35124853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.